S. Lippman

J. V. Bacus, J. W. Bacus, S. Lippman, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Head and Neck Cancer

S. Lippman, W. Hong, R. Weichselbaum, 1993, Cancer treatment and research.

Precancer Atlas to Drive Precision Prevention Trials.

A. Shilatifard, T. Rebbeck, V. Velculescu, 2017, Cancer research.

The BATTLE trial: personalizing therapy for lung cancer.

Edward S. Kim, S. Lippman, F. Khuri, 2011, Cancer discovery.

Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.

Trey Ideker, Hannah Carter, Christopher M. DeBoever, 2017, Cancer discovery.

Positive Surgical Margins in the 10 Most Common Solid Cancers

Anne Wallace, Karen Messer, Ryan K Orosco, 2018, Scientific Reports.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

James Allison, Stephen Forman, Massimo Cristofanilli, 2015, Mayo Clinic proceedings.

Protease inhibitors in oral carcinogenesis and chemoprevention.

S. Lippman, L. Matrisian, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Michael Peyton, John D. Minna, Li Shen, 2012, Clinical Cancer Research.

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

Ryan K. Orosco, Trey Ideker, Hannah Carter, 2014, Nature Genetics.

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.

D. Alberts, S. Lippman, G. Weiss, 1998, Gynecologic oncology.

Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.

Edward S. Kim, S. Lippman, F. Khuri, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT )

J. Crowley, J. Chin, I. Thompson, 2011 .

Vitamin E supplementation increased risk for prostate cancer in healthy men at a median of 7 years

I. Thompson, P. Goodman, C. Tangen, 2012 .

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

Michael Peyton, John D. Minna, Lixia Diao, 2013, Clinical Cancer Research.

An intermittent approach for cancer chemoprevention

Xiangwei Wu, S. Lippman, Scott M. Lippman, 2011, Nature Reviews Cancer.

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

S. Singletary, N. Sneige, S. Lippman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.

B. Fornage, N. Sneige, S. Lippman, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma.

N. Hu, M. Emmert-Buck, Jing Wang, 2013, The American journal of pathology.

Chemoprevention of breast cancer

P. Brown, S. Lippman, 2000, Breast Cancer Research and Treatment.

Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.

A. Sabichi, S. Lippman, B. Esmaeli, 2012, Archives of ophthalmology.

Design considerations for efficient prostate cancer chemoprevention trials.

S. Lippman, J. Lee, J. Sloan, 2001, Urology.

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

Karra A. Jones, Karra A Jones, Scott M Lippman, 2016, Nature Communications.

Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.

C. Roehrborn, J. Cadeddu, S. Lippman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, M. Lucia, 2021, Nutrition and cancer.

Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.

A. Garden, K. Ang, R. Weber, 2010, International journal of radiation oncology, biology, physics.

Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.

A. Sabichi, S. Lippman, J. Lee, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lung cancer chemoprevention: an integrated approach.

M. Spitz, S. Lippman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Apoptosis via Induction of 15-Lipoxygenase-1 in Colorectal Cancer Cells

S. Lippman, R. Lotan, I. Shureiqi, 2004, Cancer Research.

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

L J Peters, J S Lee, S. Lippman, 1990, The New England journal of medicine.

Expression β and Is Related to RA Receptor in Vivo Treatment-RA cis Than Binding to Normal Tissue , Increases after 13-Premalignant Oral Lesions , Which Occurs Less Frequently Anti-Retinoic Acid ( RA ) Antibody Binding to Human Updated

S. Lippman, Xìao-chun Xu, M. Zile, 2006 .

An A ttenuated A denovirus, O NYX-015, A s M outhwash T herapy for P remalignant O ral D ysplasia

C. Rudin, S. Lippman, W. Hong, 2006 .

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

R. Weber, S. Lippman, W. Hong, 1993, Investigational new drugs.

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Edward S. Kim, S. Lippman, F. Khuri, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.

S. Lippman, R. Lotan, W. Hong, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix 1

S. Lippman, R. Lotan, W. Hong, 2001 .

Lack of correlation between expression of retinoic acid receptor‐beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer

S. Lippman, R. Lotan, Xìao-chun Xu, 2000, Genes, chromosomes & cancer.

Lung cancer chemoprevention.

S. Lippman, F. Khuri, 2000, Seminars in surgical oncology.

Esophageal Cancer Cell Lines Associated with Retinoid Sensitivity and Colony Formation in Is β Expression and Up-Regulation of Retinoic Acid Receptor-Updated Version

S. Lippman, R. Lotan, E. Tahara, 1999 .

Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.

S. Lippman, R. Lotan, X. Liu, 1999, Cancer research.

The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels.

S. Lippman, W. Hong, H. Fritsche, 1998, Cancer detection and prevention.

Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.

S. Lippman, J. Lee, J. Mulshine, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.

S. Lippman, J. Lee, W. Hong, 1997, Annals of Oncology.

Phase I trial of 9-cis retinoic acid in adults with solid tumors.

S. Lippman, J. Kurie, W. Hong, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.

S. Lippman, J. Lee, R. Morice, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial.

S. Lippman, J. Lee, W. Hong, 2009, Journal of cancer education : the official journal of the American Association for Cancer Education.

Current status of retinoid chemoprevention of lung cancer.

S. Lippman, W. Hong, S. Benner, 1995, Oncology.

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.

S. Lippman, W. Hong, F. Fossella, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Co-carcinogenesis and field cancerization: oral lesions offer first signs.

S. Lippman, C. Flaitz, R. Devoll, 1995, Journal of the American Dental Association.

Chemoprevention of lung cancer.

S. Lippman, W. Hong, S. Benner, 1995, Chest.

Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.

S. Lippman, R. Lotan, W. Hong, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Chemoprevention of second primary tumours: a model for intervention trials.

S. Lippman, W. Hong, S. Benner, 1994, European journal of cancer.

Retinoid lung cancer prevention.

S. Lippman, W. Hong, S. Benner, 1994, Lung cancer.

Potential of retinoids in cancer prevention.

S. Lippman, W. Hong, J. Kurie, 1994, Cancer treatment reviews.

Epidemiology, biology, and chemoprevention of aerodigestive cancer

M. Spitz, S. Lippman, W. Hong, 1994, Cancer.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, W. Hong, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.

S. Lippman, W. Hong, S. Benner, 1994, Cancer research.

Retinoid chemoprevention of aerodigestive carcinogenesis

S. Lippman, W. Hong, S. Benner, 1994 .

Chemoprevention strategies for the control of cancer

S. Lippman, W. Hong, S. Benner, 1993, Cancer.

Biomarkers in aerodigestive tract chemoprevention trials

S. Lippman, R. Lotan, W. Hong, 1993 .

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

S. Lippman, W. Hong, R. Newman, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoprevention strategies in lung carcinogenesis.

S. Lippman, W. Hong, S. Benner, 1993, Chest.

The role of retinoids in preventing second lung cancers

S. Lippman, W. Hong, S. Benner, 1993 .

Chemoprevention as a form of cancer control.

S. Lippman, B. Toth, J. Martin, 1993, Journal of the American Dental Association.

Chemoprevention strategies for lung and upper aerodigestive tract cancer.

S. Lippman, W. Hong, S. Benner, 1992, Cancer research.

Determination of biomarkers for intermediate end points in chemoprevention trials.

S. Lippman, R. Lotan, W. Hong, 1992, Cancer research.

Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials

S. Lippman, W. Hong, W. Hittelman, 1992, Journal of cellular biochemistry. Supplement.

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

S. Lippman, J. Lee, J. Lee, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoprevention of head and neck cancer

S. Lippman, W. Hong, K. Heyne, 2010 .

Treatment of advanced squamous cell carcinoma of the skin with isotretinoin.

S. Lippman, F. Meyskens, 1987, Annals of internal medicine.

Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck.

S. Lippman, H. Garewal, F. Meyskens, 1989, Preventive medicine.

Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.

G. Hortobagyi, N. Sneige, S. Lippman, 1997, Cancer research.

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

S. Lippman, M. Ewer, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor

P. Tamayo, S. Lippman, Y. Samuels, 2018, Nature Communications.

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

S. Reis, W. McCaskill-Stevens, S. Lippman, 2006 .

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers

S. Lippman, J. Califano, Ji Luo, 2016, Oncotarget.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

J. Weinstein, K. Coombes, G. Mills, 2012, Cancer discovery.

Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

Edward S. Kim, Robin L. Jones, S. Lippman, 2014, Clinical Cancer Research.

Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications

R. Weber, S. Lippman, A. El‐Naggar, 2014, Clinical Cancer Research.

p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.

S. Lippman, W. Hong, J. Lee, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.

S. Lippman, J. Clifford, Xiulan Yang, 2003, Molecular cancer therapeutics.

The transcription factor GATA‐6 is overexpressed in vivo and contributes to silencing 15‐LOX‐1 in vitro in human colon cancer

Jeffrey S. Morris, S. Lippman, R. Broaddus, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer

Edward S. Kim, S. Lippman, A. Tsao, 2007 .

PHASE I/II STUDY OF GEMCITABINE, AN ACTIVE AGENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

S. Lippman, F. Fossella, P. Tarasaoff, 1995 .

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.

R. A. Robinson, S. Lippman, J. Lee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion

J. Minna, S. Lippman, I. Wistuba, 2012, Molecular Cancer Therapeutics.

Letter from the editor.

S. Lippman, 2012, Cancer Prevention Research.

Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia

D. Alberts, C. Tangen, L. Minasian, 2006, Cancer Epidemiology Biomarkers & Prevention.

Can selenium prevent colorectal cancer? A signpost from epidemiology.

S. Lippman, I. Shureiqi, A. J. Duffield-Lillico, 2004, Journal of the National Cancer Institute.

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.

S. Lippman, E. Platz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

S. Lippman, W. Hong, R. Winn, 1993, Journal of the National Cancer Institute.

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

M. Erlander, S. Lippman, M. Tewari, 2017, Clinical Cancer Research.

The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.

D. Alberts, M. Somerfield, S. Lippman, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.

S. Lippman, R. Lotan, W. Hong, 1999, Cancer research.

Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

S. Lippman, R. Lotan, J. Clifford, 1999, Cancer research.

Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.

Andrew M. Gross, T. Ideker, R. Tsien, 2015, Oral oncology.

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology

E. Fung, S. Lippman, R. Duttagupta, 2017, Molecular Cancer Therapeutics.

Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.

D. Alberts, S. Lippman, R. Herberman, 2006, Cancer research.

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

S. Lippman, S. Martino, C. Moinpour, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression

J. Ajani, S. Lippman, Y. Zou, 2005, Oncogene.

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

S. Lippman, R. Lotan, J. Lee, 2000, Journal of the National Cancer Institute.

Cigarettes: a smoking gun in cancer chemoprevention.

S. Lippman, S. Mayne, 2005, Journal of the National Cancer Institute.

COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer.

A. Sabichi, S. Lippman, 2004, Seminars in oncology.

SELECT: the selenium and vitamin E cancer prevention trial.

I. Thompson, P. Goodman, S. Lippman, 2003, Urologic oncology.

Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer☆

P. Brown, I. Thompson, H. Parnes, 2016, EBioMedicine.

The Convergent Development of Molecular-Targeted Drugs for Cancer Treatment and Prevention

S. Lippman, J. Heymach, J. Heymach, 2007, Clinical Cancer Research.

Telomere Length and Recurrence Risk after Curative Resection in Patients with Early-Stage Non–Small-Cell Lung Cancer: A Prospective Cohort Study

S. Lippman, Xifeng Wu, J. Roth, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.

Edward S. Kim, S. Lippman, J. Roth, 2009, Chest.

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.

A. Sabichi, S. Lippman, W. Hong, 2003, The Annals of thoracic surgery.

Not yet standard: retinoids versus second primary tumors.

S. Lippman, W. Hong, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mortality risk from squamous cell skin cancer.

S. Lippman, J. Lee, A. El‐Naggar, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".

S. Lippman, J. Roth, S. Swisher, 2008, Chest.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

A. Garden, S. Lippman, W. Hong, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

Edward S. Kim, S. Lippman, F. Khuri, 2009, American journal of clinical oncology.

Non-steroidal anti-inflammatory drugs and the risk of oral cancer in current and former smokers - [REMOVED]

J. Sudbø, A. Reith, S. Lippman, 2005 .

Head and Neck Cancer

S. Lippman, R. Weichselbaum, E. Vokes, 1993, Cancer Treatment and Research.

Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients

S. Lippman, J. Morrow, N. Lee, 2009, Cancer Prevention Research.

Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research.

P. Brown, H. Parnes, S. Lippman, 2007, Cancer research.

Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies

J. Sicklick, S. Lippman, A. Goodman, 2019, International journal of cancer.

Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.

S. Lippman, R. Lotan, W. Hong, 1996, Cancer research.

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

R. Bast, S. Lippman, Yin-hua Yu, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Chemoprevention of lung cancer.

S. Lippman, W. Hong, S. Benner, 1995, Chest.

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

K. Ang, S. Lippman, W. Hong, 2010, Molecular Cancer Therapeutics.

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial

I. Thompson, P. Goodman, C. Tangen, 2016, The Prostate.

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

M. Kattan, I. Thompson, P. Goodman, 2007, Journal of the National Cancer Institute.

Advances in the biology of lung cancer chemoprevention.

S. Lippman, F. Hirsch, F. Hirsch, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoic A cid R eceptor-Beta a s a P rognostic I ndicator i n Stage I N on-Small-Cell L ung C ancer

S. Lippman, F. Khuri, R. Lotan, 2000 .

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.

John V Heymach, Kevin R Coombes, Lixia Diao, 2012, Journal of the National Cancer Institute.

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

John V Heymach, Young-Ho Ahn, Roy S Herbst, 2013, Cancer research.

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial

Edward S. Kim, S. Lippman, W. Hong, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience

J. Sicklick, S. Lippman, B. Leyland-Jones, 2020, The oncologist.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, R. Morice, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second international cancer chemoprevention conference.

S. Lippman, U. Pastorino, W. Hong, 1994, Cancer research.

HER2-Amplified Salivary Duct Carcinoma: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment

S. Lippman, R. Kurzrock, G. Falchook, 2014 .

Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

M. Sporn, D. Alberts, S. Lam, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917

D. Alberts, I. Thompson, C. Tangen, 2011, Cancer Prevention Research.

Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia : SWOG S 9917

D. Alberts, I. Thompson, C. Tangen, 2011 .

COX-2 inhibitors and other NSAIDs in bladder and prostate cancer.

A. Sabichi, S. Lippman, 2003, Progress in experimental tumor research.

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.

J. Cuzick, B. Kramer, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aspirin and colorectal cancer prevention in Lynch syndrome

S. Lippman, A. Chan, 2011, The Lancet.

Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

I. Thompson, M. Lucia, H. Parnes, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer

Diane D. Liu, P. Brown, T. Cornelison, 2016, Breast Cancer Research and Treatment.

The dilemma and promise of cancer chemoprevention

S. Lippman, 2006, Nature Clinical Practice Oncology.

Letter from the Editor

S. Lippman, 2014, Cancer Prevention Research.

Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Chin, I. Thompson, P. Goodman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Chin, I. Thompson, P. Goodman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nutritional prevention of cancer: new directions for an increasingly complex challenge.

S. Lippman, A. Kristal, 2009, Journal of the National Cancer Institute.

The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, M. Lucia, 2020, The Prostate.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Michael M Lieber, J Michael Gaziano, Ian M Thompson, 2005, Journal of the National Cancer Institute.

Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.

P. Goodman, L. Minasian, S. Lippman, 2016, Free radical biology & medicine.

J. Crowley, R. Glynn, I. Thompson, 2015, JAMA ophthalmology.

Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

J. Crowley, M. Spitz, J. Stanford, 2004, Cancer Causes & Control.

The influence of finasteride on the development of prostate cancer.

Michael M Lieber, Ian M Thompson, Scott M Lippman, 2003, The New England journal of medicine.

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, C. Tangen, 2018, Carcinogenesis.

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, C. Tangen, 2017, The Prostate.

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml−1, normal DRE and negative for prostate cancer

I. Thompson, P. Goodman, C. Tangen, 2015, Prostate Cancer and Prostatic Disease.

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.

I. Thompson, P. Goodman, C. Tangen, 2015, Urology.

Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride

I. Thompson, P. Goodman, C. Tangen, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

I. Thompson, P. Goodman, C. Tangen, 2011, Cancer Causes & Control.

Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

I. Thompson, P. Goodman, C. Tangen, 2006, Journal of the National Cancer Institute.

The evaluation of micronuclei as an intermediate endpoint of bronchial carcinogenesis.

S. Lippman, R. Morice, W. Hong, 1990, Progress in clinical and biological research.

The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.

S. Lippman, D. Trump, S. Wells, 1982, The Journal of clinical endocrinology and metabolism.

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma

S. Lippman, Xifeng Wu, J. Lee, 2013, Cancer.

Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Mi-Kyoung Kim, B Nebiyou Bekele, Scott M Lippman, 2008, Cancer research.

Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.

S. Lippman, T. Thompson, W. Hong, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retinoids and Cervical Cancer

S. Lippman, A. Kudelka, J. Kavanagh, 2020 .

Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

S. Lippman, Jung Weon Lee, Hyo-Jong Lee, 2013, Journal of the National Cancer Institute.

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M. D. Anderson cancer center experience

A. Garden, R. Weber, S. Lippman, 1994, Head & neck.

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.

Edward S. Kim, S. Lippman, W. Hong, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody

S. Lippman, A. El‐Naggar, Ho-Yyoung Lee, 2011 .

Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants

Jian Gu, J Jack Lee, Yuanqing Ye, 2009, Cancer Prevention Research.

Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.

Edward S. Kim, S. Lippman, Hushan Yang, 2010, Carcinogenesis.

Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract.

M. Spitz, S. Lippman, F. Khuri, 1998, Journal of the National Cancer Institute.

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

A. Sabichi, S. Lippman, C. Logothetis, 2005, Neoplasia.

Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

J. Sicklick, S. Lippman, R. Kurzrock, 2018, Clinical Cancer Research.

Targeting mTOR in Head and Neck Cancer—Response

S. Lippman, E. Szabo, J. S. Gutkind, 2019, Clinical Cancer Research.

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus

Howard Y. Chang, V. Bafna, R. Verhaak, 2022, bioRxiv.

SerumRetinol andCarotenoidConcentrations and Prostate Cancer Risk : Results from the Prostate Cancer Prevention Trial

I. Thompson, M. Lucia, H. Parnes, 2015 .

Retinol , Carotenoids , and risk of Prostate Cancer 1 Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk : Results from the Prostate Cancer Prevention Trial

I. Thompson, M. Lucia, H. Parnes, 2015 .

Inverse Relationship between 15-Lipoxygenase-2 and PPAR- g Gene Expression in Normal Epithelia Compared with Tumor Epithelia 1

A. Sabichi, S. Lippman, C. Logothetis, 2005 .

Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.

A. Sabichi, S. Lippman, D. Menter, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Edward S. Kim, S. Lippman, F. Khuri, 2006, Journal of the National Cancer Institute.

ACCELERATED DISCOVERY 15-LOX-1: a Novel Molecular Target of Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis in Colorectal Cancer Cells

S. Lippman, R. Lotan, J. Lee, 2000 .

Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.

Jian Gu, Yuanqing Ye, Scott M Lippman, 2013, Cancer research.

Centrosomal abnormality is common in and a potential biomarker for bladder cancer

A. Sabichi, S. Lippman, H. Grossman, 2003, International journal of cancer.

13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

R. Weber, S. Lippman, W. Hong, 1992 .

Abstract LB-88: Gene expression signatures predictive of clinical outcome and tumor mutations in refractory NSCLC patients (pts) in the BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination)

Edward S. Kim, J. Weinstein, K. Coombes, 2011 .

Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis.

S. Lippman, R. Lotan, A. el-Naggar, 1999, The American journal of pathology.

Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets.

M. Spitz, S. Lippman, W. Hong, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoids as preventive and therapeutic anticancer agents (Part I).

S. Lippman, F. Meyskens, J. Kessler, 1987, Cancer treatment reports.

Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.

M. Spitz, S. Lippman, W. Hong, 2002, Cancer research.

Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.

S. Lippman, Zhengdong Liang, Xìao-chun Xu, 2003, Neoplasia.

Alleviating the Suppression of Glycogen Synthase Kinase-3β by Akt Leads to the Phosphorylation of cAMP-response Element-binding Protein and Its Transactivation in Intact Cell Nuclei*

S. Lippman, J. Clifford, A. Kikuchi, 2003, Journal of Biological Chemistry.

Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.

V. Steele, A. Sabichi, S. Lippman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cloning and characterization of the human retinoid X receptor alpha gene: conservation of structure with the mouse homolog.

S. Lippman, J. Clifford, X. Yang, 2000, Biochemical and biophysical research communications.

Retinoid chemoprevention of upper aerodigestive tract carcinogenesis.

S. Lippman, W. Hong, 1992, Important advances in oncology.

Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion.

S. Lippman, W. Hong, W. Hittelman, 1993, Journal of the National Cancer Institute.

Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.

V. Steele, S. Lippman, R. Lotan, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast 1

G. Hortobagyi, N. Sneige, S. Lippman, 2002 .

No Increased Ki 67 Expression in Ductal Carcinoma in Situ Associated with Invasive Breast Cancer 1

N. Sneige, S. Lippman, A. Sahin, 2001 .

No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer.

N. Sneige, S. Lippman, A. Sahin, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

RARbeta1': primed to fight retinoid resistance in lung carcinogenesis.

A. Sabichi, S. Lippman, Xiaochun Xu, 2005, Journal of the National Cancer Institute.

Hypermethylation of the Retinoic Acid Receptor-β2 Gene in Head and Neck Carcinogenesis

S. Lippman, R. Lotan, W. Hong, 2004, Clinical Cancer Research.

Cancer prevention and the American Society of Clinical Oncology.

B. Kramer, M. Somerfield, S. Lippman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

S. Lippman, W. Dalton, F. Meyskens, 1990, Investigational New Drugs.

Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial

D. Alberts, S. Lippman, F. Meyskens, 1988, Investigational New Drugs.

Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma

S. Lippman, R. Lotan, K. Dhingra, 1993, Investigational New Drugs.

Phase II study of Fenretinide (N-[4-Hydroxyphenyllretinamide) in advanced breast cancer and melanoma

S. Lippman, W. Dalton, L. Joffe, 2001 .

Ocular toxic effects of fenretinide.

S. Lippman, W. Dalton, F. Meyskens, 1990, Journal of the National Cancer Institute.

Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.

S. Lippman, F. Khuri, W. Hong, 2000, Seminars in oncology.

Retinoids as preventive and therapeutic anticancer agents (Part II).

S. Lippman, F. Meyskens, J. Kessler, 1987, Cancer treatment reports.

tigated in 10 families having more than one affected member.

S. Lippman, F. Arnett, D. Meyers, 1982 .

Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience

D. Kuban, K. Hunt, J. Ajani, 2008, Oncology.

Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): An analysis of the Surveillance, Epidemiology, and End Results (SEER) registry.

Edward S. Kim, S. Lippman, J. Lee, 2012 .

Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma : Results of a matched cohort study

A. Garden, K. Ang, S. Lippman, 1997 .

The changing face of Phase 1 cancer clinical trials

S. Lippman, R. Herbst, R. Kurzrock, 2009, Cancer.

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

S. Lippman, F. Khuri, W. Hong, 1998, Seminars in oncology.

Immune profiling of oral pre-malignant lesions (OPLs): An Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis.

S. Lippman, I. Wistuba, J. Lee, 2017 .

The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.

Jeffrey S. Morris, S. Lippman, B. Levin, 2005, Cancer research.

Advances in Brief 15-Lipoxygenase-1 Mediates Nonsteroidal Anti-Inflammatory Drug-induced Apoptosis Independently of Cyclooxygenase-2 in Colon Cancer Cells 1

S. Lippman, R. Lotan, I. Shureiqi, 2000 .

Micronuclei: A potential intermediate marker for chemoprevention of aerodigestive tract cancer

S. Lippman, W. Hong, M. Wargovich, 1993, Journal of cellular biochemistry. Supplement.

Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.

D. Alberts, S. Lippman, R. Lotan, 2001, Cancer research.

Skin Squamous Carcinogenesis Progressive Decreases in Nuclear Retinoid Receptors during Updated

D. Alberts, S. Lippman, R. Lotan, 2001 .

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

S. Lippman, R. Lotan, W. Hong, 1995, Cancer research.

Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer.

M. Spitz, S. Lippman, F. Khuri, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Head and Neck Cancer: Emerging Perspectives

J. Jacobs, S. Lippman, J. Ensley, 2003 .

Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.

T. Miller, S. Lippman, A. Buzaid, 1987, The American journal of medicine.

changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.

S. Lippman, W. Hong, J. Lachuer, 2016 .

13-cis-Retinoic Acid Plus Interferon α -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

S. Lippman, W. Hong, J. Kavanagh, 1992 .

Effect Of Vitamin E And Selenium On Rate Of Decline In FEV1: The Respiratory Ancillary Study To The Selenium And Vitamin E Cancer Prevention Trial (SELECT)

J. Crowley, P. Goodman, C. Tangen, 2011, ATS 2011.

Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers.

Joe Y. Chang, V Shane Pankratz, Yuanqing Ye, 2013, Cancer research.

p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.

S. Lippman, S. Strom, M. Kripke, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mutations in Human Aggressive and Nonaggressive Basal and Squamous Cell Carcinomas 1

S. Lippman, S. Strom, M. Kripke, 2003 .

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.

M. Ratain, S. Lippman, R. Stupp, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy

J. Sicklick, S. Lippman, R. Kurzrock, 2022, npj Precision Oncology.

Pseudoxanthoma elasticum: treatment of gastrointestinal hemorrhage by arterial embolization and observations on autosomal dominant inheritance.

S. Lippman, R. Pyeritz, C. Francomano, 1980, The Johns Hopkins medical journal.

KaryoCreate: a new CRISPR-based technology to generate chromosome-specific aneuploidy by targeting human centromeres

S. Lippman, Xin Zhao, D. Fenyö, 2022, bioRxiv.

Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways

S. Lippman, D. Fenyo, T. Davoli, 2022, eLife.

Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas.

T. Grogan, S. Lippman, C. Spier, 1988, Archives of pathology & laboratory medicine.

Danazol in the treatment of myelodysplastic syndromes

S. Lippman, H. Garewal, A. Buzaid, 1987, European journal of haematology.

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure.

T. Miller, S. Lippman, J. Cassady, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of danazol in pure red cell aplasia

S. Lippman, H. Garewal, B. Greenberg, 1986, American journal of hematology/oncology.

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

S. Lippman, W. Hong, H. Libshitz, 1992, Journal of the National Cancer Institute.

Lethal midline granuloma with a novel T‐Cell phenotype as found in peripheral T‐Cell lymphoma

T. Grogan, S. Lippman, C. Koopmann, 1987, Cancer.

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.

S. Lippman, W. Hong, J. Kavanagh, 1993, Journal of the National Cancer Institute.

Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study

Pamela E. Constantinou, Catherine C. Lafferty, H. Uno, 2021, Cancer Prevention Research.

Post-transplantation T cell lymphoblastic lymphoma.

T. Grogan, T. Miller, S. Lippman, 1987, The American journal of medicine.

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer

S. Lippman, G. Clayman, I. Dimery, 1992, Investigational New Drugs.

Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck

S. Lippman, W. Hong, I. Dimery, 2004, Investigational New Drugs.

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.

S. Lippman, W. Hong, I. Dimery, 1996, American journal of clinical oncology.

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.

S. Lippman, W. Hong, R. Winn, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

p 53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis 1

S. Lippman, W. Hong, J. Lee, 2001 .

Frequent inactivation of p16INK4a in oral premalignant lesions

S. Lippman, R. Lotan, W. Hong, 1997, Oncogene.

Retinoic acid and interferon in human cancer: mechanistic and clinical studies.

S. Lippman, W. Hong, E. Borden, 1994, Seminars in hematology.

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Norman Wolmark, Scott M Lippman, S. Reis, 2006, JAMA.

Investigation of PARP1 as a therapeutic target in small cell lung cancer.

J. Weinstein, K. Coombes, Jing Wang, 2012 .

Prospective Imaging Biomarker Assessment of Mortality Risk in Patients Treated with Head and Neck Radiotherapy

A. Garden, R. Weber, S. Lippman, 2011 .

Advances in Brief Retinoid Receptor-dependent and-independent Effects of N-( 4-Hydroxyphenyl ) retinamide in F 9 Embryonal Carcinoma Cells 1

S. Lippman, R. Lotan, J. Clifford, 1998 .

Abnormal septal Q waves in sickle cell disease. Prevalence and causative factors.

M. Laks, S. Lippman, L. Ginzton, 1985, Chest.

Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma

A. Garden, S. Lippman, G. Sanguineti, 1997, Cancer.

Phase I study of paclitaxel administered by ten-day continuous infusion

S. Lippman, R. Perez-soler, J. Kurie, 1998, Investigational New Drugs.

Retinoid chemoprevention of second primary tumors.

S. Lippman, W. Hong, S. Benner, 1994, Seminars in hematology.

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

S. Lippman, W. Hong, J. Kavanagh, 1992, Journal of the National Cancer Institute.

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas

D. Sahoo, S. Lippman, L. Alexandrov, 2022, bioRxiv.

Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow.

S. Lippman, P. Ness, D. Branch, 1982, The New England journal of medicine.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Quynh-Thu Le, Martin G Pomper, Levi Garraway, 2017, The Lancet. Oncology.

Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency.

S. Lippman, P. Ness, C. Conley, 1980, JAMA.

RESULTS OF A PHASE II/III TRIAL OF CELECOXIB TO PREVENT RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER

A. Sabichi, S. Lippman, H. Grossman, 2009 .

Retinoids in the chemoprevention of bladder cancer

A. Sabichi, S. Lippman, H. Grossman, 1998, Current opinion in oncology.

Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Edward S. Kim, Diane D. Liu, S. Lippman, 2014, Clinical lung cancer.

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

S. Lippman, F. Khuri, W. Hong, 2001, Cancer.

Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.

S. Lippman, D. Shin, 1999, Seminars in oncology.

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.

S. Lippman, J. Lee, W. Hong, 1997, The cancer journal from Scientific American.

Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas.

S. Lippman, R. Lotan, H. Wu, 2000, Anticancer research.

Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial? Commentary

I. Thompson, C. Tangen, S. Lippman, 2006 .

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.

T. Grogan, T. Miller, S. Lippman, 1988, The American journal of pathology.

THE EVALUATION OF PATIENTS WITH EALES' DISEASE

S. Lippman, R. Murphy, S. Fine, 1983, Retina.

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

R. Weber, S. Lippman, P. Rao, 2010, Clinical Cancer Research.

National Cancer Institute--supported cancer chemoprevention research: coming of age.

W. McCaskill-Stevens, S. Lippman, E. Hawk, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer Prevention by Delay

S. Lippman, W. Hong, W. Hong, 2002 .

Immune evasion in HPV− head and neck precancer–cancer transition is driven by an aneuploid switch involving chromosome 9p loss

S. Lippman, H. Carter, L. Alexandrov, 2021, Proceedings of the National Academy of Sciences.

Phase III prostate cancer prevention trials: are the costs justified?

I. Thompson, C. Tangen, S. Lippman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RETRACTED: Molecular based treatment of oral cancer

J. Sudbø, A. Reith, S. Lippman, 2003 .

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts

I. Thompson, P. Goodman, C. Tangen, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Crowley, I. Thompson, P. Goodman, 2009, JAMA.

Cancer chemoprevention.

S. Lippman, W. Hong, 1995, Journal of the National Cancer Institute. Monographs.

Cancer Prevention: Obstacles, Challenges and the Road Ahead.

C. Rock, J. Cuzick, D. Alberts, 2016, Journal of the National Cancer Institute.

Nonsurgical Treatments for Skin Cancer: Retinoids and α‐Interferon

S. Lippman, F. Meyskens, D. Shimm, 1988 .

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Ian M Thompson, Lori M Minasian, Scott M Lippman, 2014, Journal of the National Cancer Institute.

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

I. Thompson, S. Lippman, C. Coltman, 2007, Journal of the National Cancer Institute.

Computed tomographic findings in orbital Mucor.

S. Lippman, V. Grinnell, J. Edwards, 1985, The Western journal of medicine.

Predicting cancer development in oral leukoplakia: ten years of translational research.

S. Lippman, R. Lotan, J. Lee, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mitral valve prolapse in sickle cell disease. Presumptive evidence for a linked connective tissue disorder.

M. Laks, S. Lippman, L. Ginzton, 1984, Archives of internal medicine.

Retinoic acid and interferon combination studies in human cancer.

S. Lippman, R. Lotan, W. Hong, 1993, European journal of cancer.

Advanced basal and squamous cell carcinomas of the skin of the head and neck.

R. Weber, S. Lippman, M. Mcneese, 1990, Cancer treatment and research.

Lymph Node Metastases from Cutaneous Squamous Cell Carcinoma of the Head and Neck

Victor Prieto, B. Moore, R. Weber, 2005, The Laryngoscope.

Results of the use of vitamin A and retinoids in cutaneous malignancies.

S. Lippman, F. Meyskens, 1989, Pharmacology & therapeutics.

Molecular markers of the risk of oral cancer.

S. Lippman, W. Hong, W K Hong, 2001, The New England journal of medicine.

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

S. Lippman, W. Hong, L. Mao, 1996, Nature Medicine.

p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma

S. Lippman, W. Hong, J. Lee, 1996 .

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.

Diane D. Liu, S. Lippman, F. Khuri, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

P h a s e I I a n d B i o logic S tudy o f I nterferon A lfa, R etinoic Acid, a nd C isplatin i n A dvanced S quamous S kin C ancer

Diane D. Liu, S. Lippman, F. Khuri, 2002 .

The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease.

S. Lippman, G. Clayman, L. Ginsberg, 2001, Archives of otolaryngology--head & neck surgery.

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

S. Lippman, A. Tsao, Chung‐Han Ho, 2010, Head & neck oncology.

Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank

B. Kramer, W. McCaskill-Stevens, L. Ford, 2016, Cancer Prevention Research.

Transforming Cancer Prevention through Precision Medicine and Immune-oncology

Avrum Spira, J Jack Lee, Zigang Dong, 2016, Cancer Prevention Research.

Molecular cancer prevention: Current status and future directions

P. Brown, K. Tsai, S. Lippman, 2015, CA: a cancer journal for clinicians.

Vitamin A derivatives in the prevention and treatment of human cancer.

S. Lippman, F. Meyskens, 1988, Journal of the American College of Nutrition.

Statins and cancer prevention

Stephen B. Gruber, S. Gruber, S. Lippman, 2005, Nature Reviews Cancer.

Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia

S. Lippman, Shidan Wang, Guanghua Xiao, 2023, Cancer medicine.

Repair Capacity for UV Light–Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression

R. Weber, S. Lippman, Q. Wei, 2007, Clinical Cancer Research.

The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.

T. Grogan, T. Miller, S. Lippman, 1988, Blood.

Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing

S. Lippman, R. Evans, R. Evans, 2020, Cell Metabolism.

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.

Dan Liu, A. Garden, K. Ang, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.

E N Atkinson, N. Sneige, S. Lippman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.

A. Sabichi, N. Sneige, S. Lippman, 1999, Human pathology.

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.

S. Lippman, K. Subbaramaiah, A. Dannenberg, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.

T. Grogan, T. Miller, S. Lippman, 1988, The Journal of clinical investigation.

Chemoprevention of upper aerodigestive tract cancers: A report of the third upper aerodigestive cancer task force workshop

J S Lee, S. Lippman, R. Lotan, 1990, Head & neck.

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

S. Lippman, J. J. Lee, A. Gillenwater, 2000, Journal of the National Cancer Institute.

Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.

S. Lippman, R. Lotan, W. Hong, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retinoid‐interferon therapy of solid tumors

S. Lippman, R. Lotan, U. Schleuniger, 1997, International journal of cancer.

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2001, Journal of the National Cancer Institute.

N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.

S. Lippman, F. Khuri, R. Lotan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

M. Sporn, D. Alberts, S. Lam, 2002 .

Treatment and Prevention of Intraepithelial Neoplasia : An Important Target for Accelerated New Agent Development Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia 1

M. Sporn, D. Alberts, S. Lam, 2002 .

Retinoids, neoplasia and differentiation therapy.

S. Lippman, P. J. Davies, 1997, Cancer chemotherapy and biological response modifiers.

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

J S Lee, S. Lippman, R. Lotan, 1995, The New England journal of medicine.

MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome

R. Weber, S. Lippman, Y. Mitani, 2013, PloS one.

Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

R. Weber, S. Lippman, Nianxiang Zhang, 2013, The American journal of pathology.

Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome

P. A. Futreal, P. Stephens, R. Weber, 2011, Clinical Cancer Research.

Natural-agent mechanisms and early-phase clinical development.

S. Lippman, K. Gold, Janet Wang, 2013, Topics in current chemistry.

Increased Retinoic Acid Receptor-β4 Correlates In vivo with Reduced Retinoic Acid Receptor-β2 in Esophageal Squamous Cell Carcinoma

S. Lippman, J. Lee, Tsung-Teh Wu, 2005, Cancer Epidemiology Biomarkers & Prevention.

Human epidermal receptor 2–amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti–vascular endothelial growth factor combination treatment

S. Lippman, R. Kurzrock, G. Falchook, 2014, Head & neck.

Molecular based treatment of oral cancer.

J. Sudbø, A. Reith, S. Lippman, 2003, Oral oncology.

Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.

A. Balmain, J. Stanford, E. Ostrander, 2005, Carcinogenesis.

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development

Edward S. Kim, Jing Wang, S. Lippman, 2015, Cancer Prevention Research.

The Conundrum of Genetic “Drivers” in Benign Conditions

S. Lippman, K. Flaherty, R. Kurzrock, 2016, Journal of the National Cancer Institute.

Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.

S. Lippman, G. Clayman, R. Eckert, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer prevention: from 1727 to milestones of the past 100 years.

S. Lippman, E. Hawk, 2009, Cancer research.

Cancer Prevention Research: Back to the Future

S. Lippman, 2009, Cancer Prevention Research.

Historical Perspective Cancer Prevention Research: Back to the Future

S. Lippman, 2009 .

Cancer prevention science and practice.

S. Lippman, W. Hong, W. Hong, 2002, Cancer research.

Perspectives in Cancer Research Cancer Prevention Science and Practice 1

S. Lippman, W. Hong, W. Hong, 2002 .

Clonal genetic alterations in the lungs of current and former smokers.

J S Lee, S. Lippman, F. Khuri, 1997, Journal of the National Cancer Institute.

Leveraging premalignant biology for immune-based cancer prevention

J. Mesirov, T. Ideker, T. Rebbeck, 2016, Proceedings of the National Academy of Sciences.

Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.

S. Lippman, S. Sen, M. Hung, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Loss of Aurora A / STK 15 / BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast

S. Lippman, S. Sen, M. Hung, 2003 .

Epithelial to mesenchymal transition in head and neck squamous carcinoma

Mahitosh Mandal, R. Weber, S. Lippman, 2008, Cancer.

Molecular targets for cancer chemoprevention

Edward S. Kim, S. Lippman, W. William, 2009, Nature Reviews Drug Discovery.

Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

S. Lippman, L. R. Howe, 2008, Journal of the National Cancer Institute.

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.

S. Lippman, I. Wistuba, J. Lee, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health

G. Colditz, B. Kramer, T. Rebbeck, 2018, Cancer Prevention Research.

Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors

J. Sicklick, S. Lippman, V. Miller, 2018, JAMA oncology.

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

G. Mills, S. Lam, M. Spitz, 2006, Clinical Cancer Research.

Adenoma Recurrences After Resection of Colorectal Carcinoma: Results From the Southwest Oncology Group 9041 Calcium Chemoprevention Pilot Study

D. Alberts, S. Lippman, K. Chansky, 2003, Annals of Surgical Oncology.

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.

S. Lippman, M. V. Estrada, G. Daniels, 2021, The Lancet. Oncology.

Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium

S. Lippman, M. Wargovich, J. Loewy, 1990, International journal of cancer.

Finasteride decreases the risk of prostatic intraepithelial neoplasia.

I. Thompson, M. Lucia, H. Parnes, 2007, The Journal of urology.

Cost‐effectiveness of prostate cancer chemoprevention

C. Roehrborn, S. Lippman, Y. Lotan, 2008, Cancer.

The Cost of Prostate Cancer Chemoprevention: A Decision Analysis Model

C. Roehrborn, S. Lippman, Y. Lotan, 2006, Cancer Epidemiology Biomarkers & Prevention.

Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity*

Milind B. Suraokar, A. Sabichi, S. Lippman, 2004, Journal of Biological Chemistry.

Genetic variation in MicroRNA genes and risk of oral premalignant lesions

S. Lippman, Hushan Yang, Xifeng Wu, 2010, Molecular carcinogenesis.

J. Minna, S. Lippman, Xifeng Wu, 2013, Cancer research.

Clinical Outcomes and Biomarker Profiles of Elderly Pretreated NSCLC Patients from the BATTLE Trial

J Jack Lee, Edward S. Kim, Ignacio Wistuba, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Oral cancer prevention and the evolution of molecular-targeted drug development.

J. Sudbø, S. Lippman, W. Hong, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.

S. Lippman, W. Hong, J. Lee, 1998, Journal of the National Cancer Institute.

RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.

S. Lippman, R. Lotan, Tsung-Teh Wu, 2006, Cancer research.

The paradox of cancer genes in non-malignant conditions: implications for precision medicine

S. Lippman, R. Kurzrock, S. Kato, 2020, Genome Medicine.

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer

Edward S. Kim, Diane D. Liu, S. Lippman, 2015, Oncotarget.

Selenium effects on prostate cell growth.

A. Sabichi, S. Lippman, D. Menter, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Microenvironment and Immunology CXCR 2 Expression inTumorCells Is aPoorPrognosticFactor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Edward S. Kim, Diane D. Liu, S. Lippman, 2013 .

Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

S. Lippman, B. Leyland-Jones, R. Kurzrock, 2017, Cancer research.

Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

S. Lippman, R. Lotan, J. S. Morris, 2001, Cancer research.

Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Esophageal Cancer Cells by Restoring 15-Lipoxygenase-1 Expression 1

Jeffrey S. Morris, S. Lippman, R. Lotan, 2001 .

Cancer Small Cell Lung − Prognosis in Never Smokers with Non Overexpression : A Feature Associated with Negative Cyclic AMP Response Element-Binding Protein

Diane D. Liu, S. Lippman, I. Wistuba, 2008 .

Predictive Biomarkers and Personalized Medicine Comprehensive Biomarker Analysis and Final Ef fi cacy Results of Sorafenib in the BATTLE Trial

Edward S. Kim, Jing Wang, J. Minna, 2013 .

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

T. Grogan, T. Miller, S. Lippman, 1988 .

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

S. Lippman, R. Perez-soler, F. Fossella, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S. Kim, Scott M Lippman, Jean-Yves Douillard, 2008, The Lancet.

Epidermal growth factor receptor and K‐Ras mutations and resistance of lung cancer to insulin‐like growth factor 1 receptor tyrosine kinase inhibitors

Edward S. Kim, S. Lippman, W. Hong, 2012, Cancer.

Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.

Edward S. Kim, Y. Miller, S. Lippman, 2009, Cancer research.

Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test

N. Schork, S. Lippman, R. Kurzrock, 2022, Communications Medicine.

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

Jing Wang, S. Lippman, I. Wistuba, 2014, Nature Cell Biology.

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

J. Sicklick, S. Lippman, A. Goodman, 2020, Nature Communications.

Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.

D. Alberts, S. Lippman, R. Lotan, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of intermittent dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF- 1R) and insulin receptor (IR) in patients with advanced solid tumors.

Edward S. Kim, Robin L. Jones, S. Lippman, 2010 .

Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.

J. Ajani, S. Lippman, S. Swisher, 2005, Carcinogenesis.

Whole exome sequencing of adenoid cystic carcinoma.

M. Stratton, P. Futreal, P. Campbell, 2013, The Journal of clinical investigation.

Chapter 59 – Cancer Chemoprevention

S. Lippman, J. Lee, J. Jack Lee, 2008 .

Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.

S. Lippman, J. Lee, J. Lee, 2006, Cancer research.

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

M. Spitz, S. Lippman, J. Gu, 2011, Carcinogenesis.

Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

S Lippman, S. Lippman, S. Tucker, 2001, The Journal of molecular diagnostics : JMD.

Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients

Diane D. Liu, S. Lippman, W. Hong, 2009, Cancer Prevention Research.

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, S. Lippman, 2006, Cancer Epidemiology Biomarkers & Prevention.

Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer

Edward S. Kim, S. Lippman, W. Hong, 2018, Journal of the National Cancer Institute.

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics

S. Lippman, R. Kurzrock, P. Fanta, 2019, Molecular Cancer Therapeutics.

Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival

S. Lippman, R. Kurzrock, M. Schwaederlé, 2019, JCO precision oncology.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Michael Peyton, Li Shen, John N Weinstein, 2012, Cancer discovery.

Neoplasms of the Head and Neck

A. Sabichi, S. Lippman, G. Laramore, 2003 .

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

J. Sicklick, P. Stephens, S. Lippman, 2019, Nature Medicine.

Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions

Charles S. Coffey, Chiu-Hsieh Hsu, O. Harismendy, 2021, JCI insight.

Detection of chromosome instability of tissue fields at risk: In situ hybridization

S. Lippman, W. Hittelman, J. Ro, 1996, Journal of cellular biochemistry. Supplement.

Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort

S. Lippman, I. Wistuba, J. Lee, 2023, Cancer.

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

Edward S. Kim, S. Lippman, I. Wistuba, 2016, JAMA oncology.

ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia

Edward S. Kim, S. Lippman, W. Hong, 2009, Clinical Cancer Research.

High-Dose Fenretinide in Oral Leukoplakia

Edward S. Kim, A. Sabichi, S. Lippman, 2009, Cancer Prevention Research.

Susceptibility and Prevention Δ Np 63 Overexpression , Alone and in Combination with Other Biomarkers , Predicts the Development of Oral Cancer in Patients with Leukoplakia

Edward S. Kim, S. Lippman, W. Hong, 2009 .

The future of molecular-targeted cancer chemoprevention.

S. Lippman, 2008, Gastroenterology.

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

S. Lippman, J. Lee, V. Papadimitrakopoulou, 2008, Clinical Cancer Research.

Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer

S. Lippman, L. Alexandrov, A. Abbasi, 2023, medRxiv.

Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy

S. Lippman, E. Sokol, G. Frampton, 2019, Cancer Immunology Research.

Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies

J. Sicklick, S. Lippman, A. Goodman, 2019, JCO precision oncology.

P. Tamayo, S. Lippman, I. Tsigelny, 2018, Oncoimmunology.

Identification and characterization of the human retinoid X receptor alpha gene promoter.

D. Hewett‐Emmett, S. Lippman, J. Clifford, 2006, Gene.

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

S. Lippman, W. Hong, J. Roth, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

O. Harismendy, S. Lippman, E. Szabo, 2018, Clinical Cancer Research.

Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ‐preservation approach in patients with paranasal sinus carcinoma

Diane D. Liu, A. Garden, S. Lippman, 2003, Cancer.

Computed Tomographic Findings

Mark L. Greenberg, S. Lippman, V. Grinnell, 2005 .

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

R. Weber, S. Lippman, D. Ota, 1992, Journal of the National Cancer Institute.

Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia

S. Lippman, F. Khuri, R. Lotan, 2006, Clinical Cancer Research.

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

C. Rudin, S. Lippman, W. Hong, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.

S. Lippman, I. Wistuba, J. Erasmus, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

S. Steinberg, S. Lippman, J. Mulshine, 2004, Clinical Cancer Research.

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

J. Sicklick, S. Lippman, J. Lee, 2021, Genome medicine.

Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer.

Pamela E. Constantinou, T. Jacks, S. Lippman, 2018, Pancreas.

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non‐small cell lung cancer

S. Lippman, H. Libshitz, F. Fossella, 1991, Cancer.

Translating Germline Cancer Risk into Precision Prevention

S. Lippman, G. Chenevix-Trench, M. Yurgelun, 2017, Cell.

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer.

S. Lippman, J. Shen, F. Lopez-Diaz, 2019, Cancer research.

The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K

S. Lippman, Weiya Ma, A. Bode, 2018, Cancer Prevention Research.

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

S Lippman, S. Lippman, R. Perez-soler, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoids and chemoprevention: Clinical and basic studies

S. Lippman, W. Hong, J. Kurie, 1995, Journal of cellular biochemistry. Supplement.

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

R. Weber, S. Lippman, J. Lee, 1993, The New England journal of medicine.

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.

T. Grogan, T. Miller, S. Lippman, 1991, Leukemia & lymphoma.

Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

Christian M. Metallo, J. Sicklick, O. Harismendy, 2021, Clinical Cancer Research.

Feasibility of Image-Guided Transthoracic Core-Needle Biopsy in the BATTLE Lung Trial

Edward S. Kim, S. Lippman, W. Hong, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Therapeutic Target for Overcoming EGFR Inhibitor Resistance Resistance to EGFR and PI 3 K Inhibitors and Identifies Axl as a Mesenchymal Transition Gene Signature Predicts

Edward S. Kim, J. Weinstein, K. Coombes, 2012 .

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody

S. Lippman, Ho-Yyoung Lee, Dong-Hoon Shin, 2011, Molecular Cancer Therapeutics.

The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura.

S. Lippman, S. Foung, F. Grumet, 1988, The Western journal of medicine.

Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.

Jacqueline Kerr, Scott M Lippman, S. Lippman, 2017, The Lancet. Oncology.

Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions.

J Jack Lee, Scott M Lippman, Xifeng Wu, 2008, European journal of cancer.

Autoimmune Hemolytic Anemia With Reticulocytopenia

S. Lippman, P. Ness, C. Conley, 2017 .

Evans' syndrome as a presenting manifestation of atypical paroxysmal cold hemoglobinuria.

S. Lippman, F. Grumet, L. Levitt, 1987, The American journal of medicine.

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products.

Robert A Newman, Gabriela Mendoza, David G Menter, 2005, Cancer research.

A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors.

S. Lippman, W. Hong, F. Fossella, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Squamous metaplasia of the bronchial mucosa and its relationship to smoking.

S Lippman, S. Lippman, R. Morice, 1993, Chest.

Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease.

S. Lippman, W. Hong, Waun Ki Hong, 1989, International journal of radiation oncology, biology, physics.

The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer

S. Lippman, W. Hong, J. Lachuer, 2016, Oncotarget.

Frontiers in cancer prevention research.

A. Sabichi, S. Lippman, C. Lerman, 2003, Cancer research.

The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells

Jeffrey S. Morris, Wei Jiang, S. Lippman, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Jian Gu, Joe Y. Chang, Yuanqing Ye, 2011, Journal of the National Cancer Institute.

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma

J. Sicklick, S. Lippman, S. Ikeda, 2018, The oncologist.

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

S. Lippman, F. Fossella, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single‐arm phase II clinical trial

Edward S. Kim, S. Lippman, L. Ginsberg, 2017, Journal of the American Academy of Dermatology.

Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.

R. Collins, A. Sabichi, S. Lippman, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.

S. Lippman, N. Sonenberg, J. Califano, 2019, Cancer research.

SELECT: THE NEXT PROSTATE CANCER PREVENTION TRIAL

I. Thompson, P. Goodman, S. Lippman, 2001 .

Phase II study of gefitinib in patients with metastatic/recurrent squamous cell carcinoma of the skin.

R. Weber, S. Lippman, A. Tsao, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor

P. Tamayo, S. Lippman, Y. Samuels, 2018, Nature Communications.

Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

A. Garden, K. Ang, R. Weber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.

T. Grogan, T. Miller, S. Lippman, 1988, Blood.

Tamoxifen prevention of breast cancer: an instance of the fingerpost.

P. Brown, S. Lippman, 1999, Journal of the National Cancer Institute.

Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes

S. Lippman, A. Ries, M. Fuster, 2019, bioRxiv.

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.

T. Cornelison, N. Sneige, S. Lippman, 2015, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, C. Tangen, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

P. Brown, T. Cornelison, S. Lippman, 2012, Cancer Prevention Research.

CHAPTER 20 – Prostate Cancer

H. Parnes, S. Lippman, D. Albanes, 2006 .

Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin

A. Sabichi, S. Lippman, R. Lotan, 2010, Cancer Prevention Research.

Retinoids and interferons: combination studies in human cancer

S. Lippman, R. Lotan, J. Clifford, 2000 .

Retinoids and Interferons as Antiangiogenic Cancer Drugs

S. Lippman, J. Clifford, J. Miano, 1999 .

Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.

M. Spitz, S. Lippman, J. Gu, 2011, Carcinogenesis.

Lipoxygenase modulation to reverse carcinogenesis.

S. Lippman, I. Shureiqi, 2001, Cancer research.

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

A. Garden, S. Lippman, F. Khuri, 2002, Cancer.

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

K. Ang, S. Lippman, F. Khuri, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor γ

A. Sabichi, S. Lippman, C. Logothetis, 2006, Oncogene.

Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.

A. Sabichi, S. Lippman, C. Logothetis, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The Selenium and Vitamin E Cancer Prevention Trial

I. Thompson, P. Goodman, S. Lippman, 2003, World Journal of Urology.

SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design

I. Thompson, P. Goodman, S. Lippman, 2000, Prostate Cancer and Prostatic Diseases.

The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells

S. Lippman, Xiaopei Xi, L. Hsi, 2005, Molecular Cancer Therapeutics.

Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.

R. Weber, S. Lippman, W. Hong, 1993, Investigational new drugs.

Cancer, more than a “COVID-19 co-morbidity”

R. Schooley, S. Lippman, R. McKay, 2023, Frontiers in Oncology.

15‐Lipoxygenase‐1 transcriptional silencing by DNA methyltransferase‐1 independently of DNA methylation

S. Lippman, J. Issa, Lanlan Shen, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma.

S. Lippman, Xifeng Wu, A. Klein, 2018, European journal of cancer.

In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.

Jeffrey E. Lee, M. Spitz, R. Weber, 2005, Journal of the National Cancer Institute.

Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center.

S. Lippman, L. Ginsberg, H. Goepfert, 1996, Skull base surgery.

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry

O. Harismendy, S. Lippman, P. Mali, 2022, The Journal of biological chemistry.

Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience

I. Thompson, P. Goodman, C. Tangen, 2010, Cancer Prevention Research.

Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck

S. Lippman, W. Hong, I. Dimery, 2004, Investigational New Drugs.

Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.

S. Lippman, F. Khuri, J. Lee, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

S. Lippman, P. Philip, C. Moinpour, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses.

A. Garden, K. Ang, S. Lippman, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

T. Grogan, T. Miller, S. Lippman, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.

T. Grogan, T. Miller, S. Lippman, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors

Edward S. Kim, S. Lippman, F. Khuri, 2009, American journal of clinical oncology.

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

S. Lippman, R. Lotan, I. Shureiqi, 2000, Cancer research.

Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.

S. Lippman, A. Gillenwater, W. Hong, 1999, Archives of otolaryngology--head & neck surgery.

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

W. McCaskill-Stevens, S. Lippman, F. Khuri, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular signatures of lung cancer--toward personalized therapy.

S. Lippman, R. Herbst, 2007, The New England journal of medicine.

Retinoids in chemoprevention of head and neck carcinogenesis.

S. Lippman, W. Hong, S. Benner, 1993, Preventive Medicine.

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

S. Lippman, J. Gu, Xifeng Wu, 2012, Carcinogenesis.

Micronuclei in bronchial biopsy specimens from heavy smokers: Characterization of an intermediate marker of lung carcinogenesis

S. Lippman, R. Morice, M. Wargovich, 1992, International journal of cancer.

Reduced DNA Repair Capacity for Removing Tobacco Carcinogen–Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics

M. Spitz, R. Weber, S. Lippman, 2010, Clinical Cancer Research.

Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience.

Razelle Kurzrock, S. Lippman, R. Kurzrock, 2015 .

Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

L. Minasian, S. Lippman, J. Probstfield, 2005, Clinical trials.

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

I. Thompson, P. Goodman, S. Lippman, 2001, The Journal of urology.

Science peels the onion of selenium effects on prostate carcinogenesis.

Scott M Lippman, H. Parnes, S. Lippman, 2004, Journal of the National Cancer Institute.

Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

P. Thall, S. Lippman, K. Do, 2009, Journal of the National Cancer Institute.

Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study

A. Sabichi, I. Thompson, C. Tangen, 2006, Clinical Cancer Research.

Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants.

S. Lippman, D. K. Singh, D. Singh, 1998, Oncology.

Mitral valve prolapse in sickle cell disease: Manifestation of a generalized connective tissue disorder

M. Laks, S. Lippman, J. Uitto, 1985, American journal of hematology.

Cancer chemoprevention: progress and promise.

A. Sabichi, S. Lippman, J. Lee, 1998, Journal of the National Cancer Institute.

Biology and reversal of aerodigestive tract carcinogenesis.

S. Lippman, W. Hong, G. Clayman, 1995, Cancer treatment and research.

Chemoprevention of aerodigestive epithelial cancers.

S. Lippman, W. Hong, 1992, Advances in experimental medicine and biology.

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

I. Thompson, P. Goodman, C. Tangen, 2011, Carcinogenesis.

Treatment with HIF-1&agr; Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice

S. Lippman, R. Herbst, G. Powis, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

Joe Y. Chang, M. Spitz, J. Minna, 2010, PloS one.

Molecular epidemiology and retinoid chemoprevention of head and neck cancer.

M. Spitz, S. Lippman, F. Khuri, 1997, Journal of the National Cancer Institute.

Unprecedented Opportunities and Promise for Cancer Prevention Research

S. Lippman, E. Blackburn, T. Tlsty, 2010, Cancer Prevention Research.

Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer

A. Sabichi, H. Parnes, S. Lippman, 2008, Clinical Cancer Research.

Phase III PreventionTrial of Fenretinide in Patients with Resected Non ^ Muscle-Invasive Bladder Cancer

A. Sabichi, H. Parnes, S. Lippman, 2007 .

Primary cancer prevention trials.

S. Lippman, E. Hawk, 2000, Hematology/oncology clinics of North America.

Micronuclei, a biomarker for chemoprevention trials: Results of a randomized study in oral pre‐malignancy

S. Lippman, J. Lee, M. Wargovich, 1994, International journal of cancer.

Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules

S. Ferretti, B. Bonanni, D. Radice, 2010, Cancer Prevention Research.

Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study.

S. Lippman, J. Gu, Xifeng Wu, 2014, Carcinogenesis.

Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I–IIIA lung cancer

S. Lippman, P. Mazzone, A. Ries, 2018, Supportive Care in Cancer.

A randomized controlled trial of vitamin E and selenium on rate of decline in lung function

J. Crowley, P. Goodman, C. Tangen, 2015, Respiratory Research.

A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors Following Curative-Intent Treatment

S. Lippman, James D. Murphy, J. Kerr, 2019, bioRxiv.

Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients

S. Lippman, Xifeng Wu, Y. Ye, 2018, Scientific Reports.

13-cis-retinoic acid plus interferon-α2a in recurrent respiratory papillomatosis

R. Weber, S. Lippman, W. Hong, 1994 .

13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.

R. Weber, S. Lippman, W. Hong, 1994, Journal of the National Cancer Institute.

Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.

A. Sabichi, S. Lippman, D. Menter, 2001, Cancer research.

4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis.

R. Weber, S. Lippman, Q. Wei, 2007, The Journal of investigative dermatology.

Researchof the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

S. Lippman, A. Tsao, Chung‐Han Ho, 2010 .

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial

I. Thompson, M. Lucia, H. Parnes, 2015, Cancer Prevention Research.

Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin.

S. Lippman, R. Lotan, J. Clifford, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus

Diane D. Liu, A. Neugut, P. Brown, 2013, Cancer Prevention Research.

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction.

J. Cuzick, B. Kramer, P. Brown, 2009, Journal of oncology practice.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

J. Cuzick, B. Kramer, P. Brown, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

G. Hortobagyi, N. Sneige, S. Lippman, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Induction of retinoic acid receptor-β suppresses cyclooxygenase-2 expression in esophageal cancer cells

S. Lippman, R. Lotan, Xìao-chun Xu, 2002, Oncogene.

Phase II Clinical Trial of N-( 4-Hydroxyphenyl ) retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia 1

S. Singletary, N. Sneige, S. Lippman, 2002 .

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.

S. Lippman, W. Hong, T. Pajak, 1994, Journal of the National Cancer Institute.

Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.

R. Weber, S. Lippman, R. Lotan, 1990, Progress in clinical and biological research.

Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

M. Spitz, J. Minna, S. Lippman, 2012, Clinical Cancer Research.

Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.

S. Lippman, S. Martino, C. Gotay, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

J. Sicklick, P. Stephens, S. Lippman, 2019, Nature Medicine.

Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus.

S. Lippman, F. Arnett, D. Meyers, 1982, The American journal of medicine.

Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention.

S. Lippman, R. Lotan, W. Hong, 1999, Journal of the National Cancer Institute.

Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.

J. Wang-Rodriguez, S. Lippman, J. Califano, 2017, Oral oncology.

Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.

S. Lippman, R. Winn, W. Hong, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique.

S. Lippman, Zhengdong Liang, Y. Shimada, 2003, Cancer research.

Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography.

A. Garden, K. Ang, S. Lippman, 1996, International Journal of Radiation Oncology, Biology, Physics.

Does the level of prostate cancer risk affect cancer prevention with finasteride?

I. Thompson, C. Tangen, H. Parnes, 2008, Urology.

Metastatic adenocarcinoma of the endometrium treated with 13‐cis‐retinoic acid plus interferon‐α

S. Lippman, A. Kudelka, R. Freedman, 1993, Anti-cancer drugs.

Non-Invasive Monitoring of Urinary KRAS Circulating Tumor DNA for Treatment Response and Minimal Residual Disease in Patients with Lung Adenocarcinoma.

M. Erlander, S. Lippman, R. Kurzrock, 2015 .

Kinetic monitoring of EGFR T790M in urinary circulating tumor DNA to predict radiographic progression and response in patients with metastatic lung adenocarcinoma.

M. Erlander, S. Lippman, R. Kurzrock, 2015 .

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

S. Lippman, S. Kesari, R. Kurzrock, 2016, Molecular Cancer Therapeutics.

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology

Richard B. Schwab, Razelle Kurzrock, Santosh Kesari, 2015, Oncotarget.

Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.

S. Lippman, E. Eisenhauer, W. Hong, 1994, Leukemia.

Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer.

S. Lippman, D. V. Von Hoff, W. Hong, 1993, Anti-cancer drugs.

Second‐look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration

S. Lippman, J. Davis, D. Slymen, 1988, Cancer.

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.

I. Thompson, P. Goodman, C. Tangen, 2007, Journal of Clinical Oncology.

Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.

I. Thompson, P. Goodman, C. Tangen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer prevention education at the M. D. Anderson Cancer Center.

S. Lippman, R. Chamberlain, B. Levin, 2009, Journal of cancer education : the official journal of the American Association for Cancer Education.

Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.

S. Lippman, W. Hong, W. Hong, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer chemoprevention.

S. Lippman, W. Hong, W K Hong, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.

S. Lippman, J. Lee, W. Hong, 1997, Journal of the National Cancer Institute.

The influence of resection and aneuploidy on mortality in oral leukoplakia.

J. Sudbø, A. Reith, S. Lippman, 2004, The New England journal of medicine.

An Attenuated Adenovirus , ONYX-015 , As Mouthwash Therapy for Premal ignant

C. Rudin, S. Lippman, W. Hong, 2003 .

Oral Premalignant Lesions Chromosome Polysomy and Histological Characteristics in Updated

S. Lippman, W. Hong, W. Hittelman, 2001 .

The Biology Behind Protease Inhibitors in Oral Carcinogenesis and Chemoprevention

S. Lippman, L. Matrisian, 2000 .

p 53 Expression : Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma

S. Lippman, W. Hong, J. Lee, 1996 .

Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer.

M. J. Gallagher, S. Lippman, T. Pajak, 1994, Journal of the National Cancer Institute.

Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture.

S. Lippman, W. Hong, G. Wolf, 1993, Cancer research.

Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.

D. Alberts, S. Lippman, K. Hatch, 1995, Gynecologic oncology.

Lennert's lymphoma: A clinicopathologic study with emphasis on phenotype and its relationship to survival

T. Grogan, T. Miller, S. Lippman, 1988, Cancer.

Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention

Edward S. Kim, M. Spitz, S. Lippman, 2012, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine Genetic Variants in the PI 3 K / PTEN / AKT / mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor / Recurrence Risk and Response to Retinoid Chemoprevention

Edward S. Kim, M. Spitz, S. Lippman, 2012 .

Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck

M. Spitz, S. Lippman, M. Huber, 1995, Current opinion in oncology.

Sleep and Breathing … and Cancer?

S. Lippman, A. Malhotra, P. Peppard, 2016, Cancer Prevention Research.

Prevention of prostate cancer with finasteride: US/European perspective.

I. Thompson, S. Lippman, C. Coltman, 2003, European urology.

Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma.

S. Lippman, D. Moore, R. Pazdur, 1995, American journal of clinical oncology.

Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.

S. Lippman, W. Hong, S. Benner, 1995, Seminars in Oncology.

Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC).

P. A. Futreal, Jing Wang, S. Lippman, 2019, Journal of Clinical Oncology.

Nonsurgical treatments for skin cancer: retinoids and alpha-interferon.

S. Lippman, F. Meyskens, D. Shimm, 1988, The Journal of dermatologic surgery and oncology.

Positive Surgical Margins in the 10 Most Common Solid Cancers

S. Lippman, James D. Murphy, C. Kane, 2018, Scientific Reports.

913: Results of a Randomized Chemoprevention Trial with Fenretinide in Non-Muscle Invasive Bladder Cancer

A. Sabichi, S. Lippman, C. Dinney, 2005 .

Intermediate end point markers in chemoprevention trials of lung cancer

S. Lippman, W. Hong, R. Morice, 1997 .

KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres

S. Lippman, D. Fenyö, Sarah Keegan, 2023, Cell.

Combined Targeting of the Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways

S. Lippman, K. Subbaramaiah, A. Dannenberg, 2005, Clinical Cancer Research.

Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan

S. Lippman, J. Gu, Xifeng Wu, 2016, Scientific Reports.

Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)

Diane D. Liu, G. Gladish, S. Lippman, 2007 .

Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall‐cell lung cancer

Edward S. Kim, Diane D. Liu, G. Gladish, 2010, Cancer.

Metformin inhibits progression of Head and Neck Squamous Cell Carcinoma by acting Directly on Carcinoma Initiating Cells.

P. Tamayo, S. Lippman, Zhiyong Wang, 2019, Cancer research.

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

S. Lippman, J. S. Morris, I. Shureiqi, 2006, Oncogene.

Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)

Edward S. Kim, S. Lippman, W. Hong, 2005 .

Chromosome polysomy and histological characteristics in oral premalignant lesions.

S. Lippman, W. Hong, W. Hittelman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The convergence of cancer prevention and therapy in early-phase clinical drug development.

S. Lippman, J. Abbruzzese, 2004, Cancer cell.

The Ability of Bilirubin in Identifying Smokers with Higher Risk of Lung Cancer: A Large Cohort Study in Conjunction with Global Metabolomic Profiling

Dong Liang, Wong-Ho Chow, Yuanqing Ye, 2014, Clinical Cancer Research.

A quantitatively scored cancer-risk assessment tool: its development and use.

S. Lippman, F. Meyskens, T. Bassford, 1992, Journal of cancer education : the official journal of the American Association for Cancer Education.

A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment

S. Lippman, James D. Murphy, J. Kerr, 2019, American journal of physical medicine & rehabilitation.

Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.

Dong Soon Choi, Scott M Lippman, S. Lippman, 2011, Blood.

Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy

S. Lippman, J. Califano, F. Torriani, 2021, Cancer medicine.

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

Edward S. Kim, Diane D. Liu, S. Lippman, 2012, Cancer.

Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.

S. Lippman, I. Shureiqi, I. Weinstein, 2005, Cancer research.

Activation of Protein Kinase G Upregulates Expression of 15-Lipoxygenase-1 in Human Colon Cancer Cells

S. Lippman, I. Shureiqi, I. Weinstein, 2005 .

Looking Forward to 2013—Saluting the Exceptional Year in 2012

S. Lippman, 2013, Cancer Prevention Research.

p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas.

S. Lippman, G. Lozano, G. Clayman, 2001, Carcinogenesis.

Recent advances in cancer chemoprevention.

S. Lippman, R. Lotan, W. Hong, 1991, Cancer cells.

Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.

S. Lippman, A. Sahin, Jinsong Liu, 2004, International journal of oncology.

Changes in Serum Proteomic Patterns by Presurgical α-Tocopherol and l-Selenomethionine Supplementation in Prostate Cancer

A. Sabichi, S. Lippman, C. Wood, 2005, Cancer Epidemiology Biomarkers & Prevention.

Preliminary activity in adrenocortical tumor (ACC) in phase I dose escalation study of intermittent oral dosing of OSI-906, a small-molecule insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor in patients with advanced solid tumors.

S. Lippman, S. Kaye, C. Carden, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The non-coding landscape of head and neck squamous cell carcinoma

Andrew Hinton, Jessica Wang-Rodriguez, Jennifer R. Grandis, 2016, Oncotarget.

GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.

S. Lippman, R. Lotan, J. Lee, 2002, Cancer research.

In This Issue

S. Lippman, 2012, Cancer Prevention Research.

Outcomes study of a course in breast-cancer screening.

S. Lippman, M. Ford, M. A. Hernández, 2009, Journal of cancer education : the official journal of the American Association for Cancer Education.

Chronic In fl ammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

I. Thompson, P. Goodman, C. Tangen, 2014 .

Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden

S. Lippman, R. Kurzrock, A. Boichard, 2021, Journal of Hematology & Oncology.

Morphometric Nuclear Grading of Intraepithelial Neoplastic Lesions with Applications to Cancer Chemoprevention Trials 1

J. V. Bacus, S. Lippman, J. Bacus, 1999 .

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

S. Lippman, J. J. Lee, W. Hong, 1996, Journal of the National Cancer Institute.

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.

S. Lippman, A. Maitra, A. Klein, 2019, Journal of Clinical Oncology.

Matrix-Metalloproteinases in Head and Neck Carcinoma–Cancer Genome Atlas Analysis and Fluorescence Imaging in Mice

Andrew M. Gross, T. Ideker, R. Tsien, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Fluorescence Imaging in Mice Cancer Genome Atlas Analysis and − Matrix-Metalloproteinases in Head and Neck Carcinoma

Andrew M. Gross, T. Ideker, R. Tsien, 2014 .

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.

S. Lippman, W. Hong, I. Wistuba, 2012 .

Edward S. Kim, M. Spitz, S. Lippman, 2010, Carcinogenesis.

Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck.

S. Lippman, W. Hong, I. Dimery, 1994, Investigational new drugs.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

S. Lippman, A. Partin, E. Klein, 2001, Urology.

A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).

A. Sabichi, S. Lippman, H. Tran, 2010 .

M. Spitz, J. Minna, S. Lippman, 2014, Clinical pharmacology and therapeutics.

13-cis-retinoic acid and cancer chemoprevention.

S. Lippman, W. Hong, 1992, Journal of the National Cancer Institute. Monographs.

Effect of age on risk of second primary colorectal cancer.

Jeffrey S. Morris, S. Lippman, B. Levin, 2001, Journal of the National Cancer Institute.

during NSAID-induced Apoptosis in Colorectal Cancer Cells GATA-6 Transcriptional Regulation of 15-Lipoxygenase-1 Updated

S. Lippman, R. Lotan, J. Lee, 2002 .

Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention.

S. Lippman, R. Lotan, B. Levin, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Algorithmic Guided Screening of Drug Combinations of Arbitrary Size for Activity against Cancer Cells

Li Mao, Paul Damien, Elmira Popova, 2022 .

Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).

S. Lippman, R. Lotan, I. Wistuba, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical impact ratings: F ★★★★★✩✩ O ★★★★★✩✩

S. Lippman, 2009 .

Minimally increased risk of cerebrovascular occlusive disease or intracerebral hemorrhage in patients on bevacizumab treatment and association with intracerebral malignancies

S. Lippman, R. Herbst, Y. Oh, 2008 .

Open Access RESEARCH

S. Lippman, A. Tsao, J. Pietenpol, 2010 .

Open Access Research

S. Lippman, T. Ravasi, A. Tsao, 2008 .

Characterization of HPV and host genome interactions in primary head and neck cancers

Chandra Sekhar Pedamallu, Angeliki Pantazi, Joshua M. Stuart, 2014, Proceedings of the National Academy of Sciences.

RETRACTED: Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study

J. Sudbø, A. Reith, S. Lippman, 2005, The Lancet.

Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.

S. Lippman, J. Geller, J. Albert, 1979, Progress in clinical and biological research.

p53 and retinoid chemoprevention of oral carcinogenesis.

S. Lippman, R. Lotan, J. Lee, 1995, Cancer research.

The paradox of cancer genes in non-malignant conditions: implications for precision medicine

S. Lippman, R. Kurzrock, S. Kato, 2020, Genome Medicine.

Advances in the development of retinoids as chemopreventive agents.

S. Lippman, R. Lotan, S. Lippman, 2000, The Journal of nutrition.

J. Cuzick, P. Brown, S. Lippman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients

S. Lippman, Xifeng Wu, Y. Ye, 2018, Scientific Reports.

Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer

S. Lippman, C. Dasanu, S. Plaxe, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents.

S. Lippman, D. K. Singh, 1998, Oncology.

Abstract 3821: A prognostic model of head and neck cancer ties TP53 mutation to 3p loss

Andrew M. Gross, Charles S. Coffey, T. Ideker, 2014 .

Immunological and classical subtypes of oral premalignant lesions

S. Lippman, L. Mao, A. Viari, 2018, Oncoimmunology.

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population

S. Lippman, R. Kurzrock, Shai Rosenberg, 2023, Molecular oncology.

Randomized placebo-controlled trial (RCT) of erlotinib for prevention of oral cancer (EPOC).

S. Lippman, D. Shin, A. Gillenwater, 2014 .

The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer

S. Lippman, J. Lachuer, C. Caulin, 2016 .

Somatic 9p24.1 alterations in HPV– head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity

S. Lippman, L. Alexandrov, W. Cavenee, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse

S. Lippman, H. Carter, G. Frampton, 2023, Journal of Immunotherapy and Precision Oncology.

Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy.

T. Wilt, P. Scardino, I. Thompson, 2014, Journal of the National Cancer Institute.

Phase I evaluation of vandetanib with radiation therapy (RT) ± cisplatin in previously untreated advanced head and neck squamous cell carcinoma (HNSCC).

S. Lippman, D. Raben, E. Cohen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma.

Jeffrey E. Lee, S. Lippman, I. Wistuba, 2010 .

The influence of finasteride on the development of prostate cancer.

I. Thompson, P. Goodman, C. Tangen, 2003, The New England journal of medicine.

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.

I. Thompson, P. Goodman, C. Tangen, 2007, The Journal of urology.

Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

J. Crowley, M. Spitz, J. Stanford, 2004, Cancer Causes and Control.

Cyclooxygenase‐2 gene polymorphisms reduce the risk of oral premalignant lesions

S. Lippman, Hushan Yang, Xifeng Wu, 2009, Cancer.

JAK: Not Just Another Kinase.

S. Lippman, R. Kurzrock, Ruchi P Agashe, 2022, Molecular cancer therapeutics.

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

S. Lippman, A. Tsao, C. Etzel, 2010, Head & neck oncology.

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

S. Lippman, J. Gu, Xifeng Wu, 2012, Carcinogenesis.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Mark E. Davis, E. Mardis, A. Butte, 2017, The Lancet Oncology.

Telomere Length and Recurrence Risk after Curative Resection in Patients with Early-Stage Non–Small-Cell Lung Cancer: A Prospective Cohort Study

S. Lippman, Xifeng Wu, J. Roth, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

S. Lippman, B. Leyland-Jones, R. Kurzrock, 2017, Cancer research.

Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells

P. Damien, G. Mills, S. Lippman, 2009, Molecular Cancer Therapeutics.

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

R. Weber, S. Lippman, P. Rao, 2010, Clinical Cancer Research.

Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride

P. Goodman, C. Tangen, S. Lippman, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

M. Kattan, P. Goodman, C. Tangen, 2007, Journal of the National Cancer Institute.

Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications

R. Weber, S. Lippman, P. Rao, 2014, Clinical Cancer Research.